California to Vote on Ban of Flavored Tobacco Products

Sep.13.2022
California lawmakers consider ban on flavored tobacco products, including e-cigarettes, to reduce harm to youth and public health.

California state senator Steve Glazer, D-Orinda, displayed a box of flavored electronic cigarettes as he discussed his support for a measure proposed by state senator Jerry Hill, D-San Mateo (left), that would ban flavored tobacco products from being sold in stores and vending machines across California, pending approval from the legislative body and signature from the governor. Assembly member Kevin McCarty from Sacramento is pictured on the right. (Source: Rich Pedroncelli)


On November 8, 2022, Californians will have the opportunity to vote on a measure that would ban the sale of flavored tobacco products statewide. Proposition 31 would overturn Senate Bill 793, which passed in 2020 but has not yet gone into effect, and would specifically prohibit the sale of flavored e-cigarettes, menthol cigarettes, as well as fruit and candy-flavored products like sour apple and gummy bear.


If there were no ban, Californians would be better off, and this has had a disproportionate impact on the e-cigarette market. By pushing users towards flavorless tobacco products, typically cigarettes, it does more harm than good. Tobacco policies should focus on harm reduction - the harm of e-cigarettes is lower than smoking.


On one hand, it should be noted that the lawmakers of the state deserve congratulations for recognizing the cost of SB 793. For instance, because the initial version of the ban included pipe tobacco, Doug Shaw of Sanctuary Tobacco in San Luis Obispo planned to close his store. Fortunately, the law was amended to exempt pipe tobacco.


National tobacco policies have often gone too far. When it comes to flavored e-cigarette products, the focus is on minors. As California lawmakers who authored SB 793 noted, "the tobacco industry uses candy, fruit, and other enticing flavors as strategic weapons to addict a new generation.


Concerns about minors are an important policy issue, but the scope is too broad. Adults also enjoy similar tastes. Upon perusing any cocktail menu at a bar, one can find similar-tasting drinks. Don't forget the fruit-flavored alcoholic sodas and craft beers on grocery store shelves.


Fruit-flavored electronic cigarettes are not only attractive to adults, but they may also be safer than traditional cigarettes which may be banned in the state. Burning tobacco in a paper "tube" releases nicotine, as well as tar and other additives into the smoker's lungs. As far as reducing the harm of tobacco products, banning flavored tobacco (primarily electronic cigarettes) products would do more harm than good.


The majority of the harm from smoking bans arises from the increased difficulty of quitting smoking. Studies show that e-cigarettes can be a valuable tool to help people quit smoking.


Journalist Jacob Grier, who focuses on the tobacco and alcohol industries, recently pointed out that England's health department is actively promoting electronic cigarettes as a smoking cessation tool. Californians would be better off looking at these international examples, instead of allowing SB 793 to take effect.


The safety of e-cigarettes does not mean they are entirely risk-free. They may pose a danger of exposing users to carcinogenic substances. However, a balanced approach that considers economic and public health factors should focus on limiting and reducing harm. As James Prieger, an economist at Pepperdine University, notes in his research on e-cigarettes, "there is significant uncertainty regarding their long-term effects, but it is almost certainly true that using e-cigarettes is healthier than smoking.


However, despite this, the issue of tobacco use among minors remains an important public policy issue. However, we can once again find a reason to be concerned that the ban may do more harm than good. Adolescents who use electronic cigarettes are also adolescents who smoke. In a hypothetical group of 100 high school students who do not use tobacco or nicotine products, only 2% regularly use electronic cigarettes.


Research is currently underway regarding widespread bans on menthol and flavored tobacco, such as California's SB 793. However, previous age restrictions on e-cigarettes have not effectively reduced tobacco use. Dr. Michael Pesko of Cornell University studied the impact of age restrictions on the purchase of e-cigarettes. His research shows that these restrictions have not stopped students from consuming nicotine - they simply switch from e-cigarettes to traditional cigarettes.


SB 793 also affects certain groups, who often prefer menthol cigarettes (which were introduced in the 1950s and hold 30% of the US market). This encourages more smuggling activity which is now undermining the state's revenue from consumption taxes and could lead to more dangerous interactions between smokers and the police.


Californians should be aware of the inevitable alternatives that come with the regulation of nicotine sources. Banning flavored e-cigarette liquids may lead some people to switch to riskier smoking alternatives. Public health policies should reflect the relative risks of consumption activities - even flavored tobacco products are not as dangerous as traditional cigarettes.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry-related communication and research.


Due to limitations in the level of translation, the translated article may not fully express the same meaning as the original. Please refer to the original article.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign related statements and stances.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-listed vape company iSpire Technology has restructured its leadership team, with Tuanfang Liu becoming the company’s sole chief executive officer (CEO) and Michael Wang appointed CEO of Aspire North America. The move ends iSpire’s previous co-CEO structure and creates clearer responsibilities between group strategy and regional execution. Separately, BTIG initiated coverage on iSpire Technology with a Buy rating and a $3.50 price target, identifying ODM growth opportunities as a key investment factor.
Jul.27
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
Germany Seizes 56 Pallets of Illegal Vapes, Probe Estimates €1.8 Million Tax Loss
Germany Seizes 56 Pallets of Illegal Vapes, Probe Estimates €1.8 Million Tax Loss
German authorities have seized dozens of pallets of illegal disposable vapes in a criminal investigation, with the products estimated to have caused at least €1.8 million in tax losses. The case has also raised concerns over cross-border supply chains linked to unauthorized nicotine products entering the European market.
Jul.14